These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32473242)

  • 1. Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer.
    Hou Z; Sun L; Xu F; Hu F; Lan J; Song D; Feng Y; Wang J; Luo X; Hu J; Wang G
    Cancer Lett; 2020 Sep; 487():63-73. PubMed ID: 32473242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
    Orouji E; Federico A; Larribère L; Novak D; Lipka DB; Assenov Y; Sachindra S; Hüser L; Granados K; Gebhardt C; Plass C; Umansky V; Utikal J
    Int J Cancer; 2019 Dec; 145(12):3462-3477. PubMed ID: 31131878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis.
    Yu L; Ye F; Li YY; Zhan YZ; Liu Y; Yan HM; Fang Y; Xie YW; Zhang FJ; Chen LH; Ding Y; Chen KL
    Carcinogenesis; 2020 Jul; 41(5):678-688. PubMed ID: 31306481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SETDB1 promotes the progression of colorectal cancer via epigenetically silencing p21 expression.
    Cao N; Yu Y; Zhu H; Chen M; Chen P; Zhuo M; Mao Y; Li L; Zhao Q; Wu M; Ye M
    Cell Death Dis; 2020 May; 11(5):351. PubMed ID: 32393761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
    Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
    Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer
    Tian J; Wang W; Zhu J; Zhuang Y; Qi C; Cai Z; Yan W; Lu W; Shang A
    J Immunol Res; 2022; 2022():4012920. PubMed ID: 35497876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Methyltransferase SETDB1 Promotes the Progression of Colorectal Cancer by Inhibiting the Expression of TP53.
    Chen K; Zhang F; Ding J; Liang Y; Zhan Z; Zhan Y; Chen LH; Ding Y
    J Cancer; 2017; 8(16):3318-3330. PubMed ID: 29158805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
    Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SETDB1 promotes gastric carcinogenesis and metastasis via upregulation of CCND1 and MMP9 expression.
    Shang W; Wang Y; Liang X; Li T; Shao W; Liu F; Cui X; Wang Y; Lv L; Chai L; Qu L; Zheng L; Jia J
    J Pathol; 2021 Feb; 253(2):148-159. PubMed ID: 33044755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetuximab promotes SN38 sensitivity via suppression of heat shock protein 27 in colorectal cancer cells with wild-type RAS.
    Ishida T; Ishii Y; Tsuruta M; Okabayashi K; Akimoto S; Koishikawa K; Hasegawa H; Kitagawa Y
    Oncol Rep; 2017 Aug; 38(2):926-932. PubMed ID: 28656305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-141-3p affected proliferation, chemosensitivity, migration and invasion of colorectal cancer cells by targeting EGFR.
    Xing Y; Jing H; Zhang Y; Suo J; Qian M
    Int J Biochem Cell Biol; 2020 Jan; 118():105643. PubMed ID: 31704502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer.
    Zhao LH; Li Q; Huang ZJ; Sun MX; Lu JJ; Zhang XH; Li G; Wu F
    Cell Death Dis; 2021 Oct; 12(11):974. PubMed ID: 34671018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.
    Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T
    PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma.
    Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
    Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.
    Shuai W; Wu J; Chen S; Liu R; Ye Z; Kuang C; Fu X; Wang G; Li Y; Peng Q; Shi W; Li Y; Zhou Q; Huang W
    Cancer Lett; 2018 May; 422():56-69. PubMed ID: 29458143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Silencing of CHOP Expression by the Histone Methyltransferase EHMT1 Regulates Apoptosis in Colorectal Cancer Cells.
    Kim K; Ryu TY; Lee J; Son MY; Kim DS; Kim SK; Cho HS
    Mol Cells; 2022 Sep; 45(9):622-630. PubMed ID: 35748228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression.
    Gao H; Yu Z; Bi D; Jiang L; Cui Y; Sun J; Ma R
    Mol Cell Biochem; 2007 Nov; 305(1-2):35-44. PubMed ID: 17577629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations.
    Lee J; Lee I; Han B; Park JO; Jang J; Park C; Kang WK
    J Natl Cancer Inst; 2011 Apr; 103(8):674-88. PubMed ID: 21398618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.
    Cacciola NA; Calabrese C; Malapelle U; Pellino G; De Stefano A; Sepe R; Sgariglia R; Quintavalle C; Federico A; Bianco A; Uchimura Bastos A; Milone M; Bellevicine C; Milone F; Carlomagno C; Selvaggi F; Troncone G; Fusco A; Pallante P
    Mol Carcinog; 2016 May; 55(5):793-807. PubMed ID: 25917796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer.
    Carvalho S; Freitas M; Antunes L; Monteiro-Reis S; Vieira-Coimbra M; Tavares A; Paulino S; Videira JF; Jerónimo C; Henrique R
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2127-2137. PubMed ID: 30105513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.